Trails Edge Capital Partners, LP
Q3 2026 13F filing
Updated 6 days ago38 disclosed positions worth $695.9M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LB PHARMACEUTICALS INC | $44.1M | 1.15M | 6.34% | — |
| 2 | B BIOMARIN PHARMACEUTICAL INC | $40M | 667.0K | 5.75% | — |
| 3 | N NURIX THERAPEUTICS INC | $37.3M | 1.57M | 5.36% | — |
| 4 | O OBSIDIAN THERAPEUTICS INC | $34.3M | 2.50M | 4.92% | — |
| 5 | I IMMUNOCORE HLDGS PLC | $32.2M | 1.06M | 4.63% | — |
| 6 | F 4D MOLECULAR THERAPEUTICS IN | $31.9M | 2.23M | 4.58% | — |
| 7 | D DESIGN THERAPEUTICS INC | $31.4M | 2.50M | 4.52% | — |
| 8 | C CYTOKINETICS INC | $31M | 470.0K | 4.45% | — |
| 9 | T FIRST TRACKS BIOTHERAPEUTICS | $28.8M | 814.0K | 4.15% | — |
| 10 | F FAETH THERAPEUTICS INC | $28M | 941.7K | 4.02% | — |
| 11 | T TANGO THERAPEUTICS INC | $27.4M | 1.10M | 3.94% | — |
| 12 | N NEUROGENE INC | $26.8M | 964.9K | 3.86% | — |
| 13 | C CELLDEX THERAPEUTICS INC NEW | $24.8M | 765.0K | 3.56% | — |
| 14 | A AVALO THERAPEUTICS INC | $23M | 1.50M | 3.30% | — |
| 15 | C CONTINEUM THERAPEUTICS INC | $22.7M | 1.69M | 3.27% | — |
| 16 | T TYRA BIOSCIENCES INC | $21.9M | 1.00M | 3.14% | — |
| 17 | M MOONLAKE IMMUNOTHERAPEUTICS | $19.7M | 1.68M | 2.82% | — |
| 18 | I INHIBIKASE THERAPEUTICS INC | $18.7M | 9.11M | 2.69% | — |
| 19 | I INHIBRX BIOSCIENCES INC | $17M | 170.0K | 2.44% | — |
| 20 | X XENON PHARMACEUTICALS INC | $14.9M | 400.0K | 2.14% | — |
| 21 | C CAMP4 THERAPEUTICS CORP | $14.6M | 3.63M | 2.10% | — |
| 22 | ? N/A ALTIMMUNE INC | $12.1M | 4.23M | 1.74% | — |
| 23 | I OPUS GENETICS INC | $11.7M | 2.41M | 1.68% | — |
| 24 | K KAILERA THERAPEUTICS INC | $10.8M | 943.0K | 1.55% | — |
| 25 | S SOL-GEL TECHNOLOGIES LTD | $10.4M | 139.4K | 1.49% | — |
| 26 | I INVENTIVA SA | $9.8M | 2.66M | 1.41% | — |
| 27 | T ENTRADA THERAPEUTICS INC | $9.1M | 1.43M | 1.30% | — |
| 28 | A AURA BIOSCIENCES INC | $9.1M | 1.44M | 1.30% | — |
| 29 | R RESEARCH ALLIANCE CORP III | $8.9M | 822.5K | 1.28% | — |
| 30 | ? N/A X4 PHARMACEUTICALS INC | $7.5M | 2.57M | 1.07% | — |
| 31 | C CENTURY THERAPEUTICS INC | $7.1M | 4.13M | 1.02% | — |
| 32 | P PROMIS NEUROSCIENCES INC | $6M | 557.1K | 0.87% | — |
| 33 | R RESEARCH ALLIANCE CORP IV | $6M | 500.0K | 0.86% | — |
| 34 | I IMAGENEBIO INC | $5M | 1.09M | 0.72% | — |
| 35 | N MINERVA NEUROSCIENCES INC | $4.8M | 1.42M | 0.68% | — |
| 36 | ? N/A TCGX ACQUISITION CORP | $3.1M | 250.0K | 0.45% | — |
| 37 | V VTV THERAPEUTICS INC | $2.4M | 77.0K | 0.34% | — |
| 38 | O ONKURE THERAPEUTICS INC | $1.7M | 619.6K | 0.24% | — |